🇺🇸 FDA
Company

Dianthus

Dianthus Therapeutics, Inc. /DE/

DNTH pharma USA

Quick answer

Dianthus is a pharma company (DNTH) headquartered in NEW YORK, NY, USA with 3 tracked pipeline programs.

Pipeline (3)

project

Claseprubart

Chronic Inflammatory Demyelinating Polyneuropathy

Phase 3 · small_molecule · active

1 trials project

Claseprubart

Multifocal Motor Neuropathy

Phase 2 · small_molecule · active

1 trials project

DNTH103

Myasthenia Gravis, Generalized

Phase 2 · small_molecule · active

1 trials

Patents (2)

patent

US 12252550

Antibodies that bind to C1S and uses thereof

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12110344

Antibodies that bind to cis and uses thereof

Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)